Skip to main content

Advertisement

Log in

Lymphovascular invasion, perineural invasion, and tumor budding are prognostic factors for stage I colon cancer recurrence

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

A Correction to this article was published on 04 April 2020

This article has been updated

Abstract

Background

The diagnostic impact of lymphovascular invasion (LVI), perineural invasion (PNI), and tumor budding in stage I colon cancer is currently unknown. This study was conducted to evaluate the prognostic impact of LVI, PNI, and tumor budding in stage I colon cancer.

Methods

From January 2008 to December 2013, 720 patients who underwent curative surgery and were diagnosed with stage I colon cancer were reviewed retrospectively. These patients were categorized into two groups based on LVI, PNI, and tumor budding: the no risk group (n = 566) and risk group (n = 154).

Results

Median follow-up period was 103.5 months, and the 5-year disease-free survival rate of the risk group was significantly lower than that of the no risk group (p = 0.025). In multivariate analysis, only the risk group had prognostic factors for 5-year disease-free survival (p = 0.036). In addition, only differentiation was an independent predictor in the risk group (p = 0.009).

Conclusion

LVI, PNI, and tumor budding are strong prognostic factors for stage I colon cancer. Therefore, patients with positive LVI, PNI, or tumor budding should receive close follow-up and potentially be considered for chemotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Change history

  • 04 April 2020

    The name of the author of the original published version of this article was presented incorrectly. The author name <Emphasis Type="Bold">“JungWook Huh”</Emphasis> should have been presented as <Emphasis Type="Bold">“Jung Wook Huh”.</Emphasis>

References

  1. Huh JW, Kim HR, Kim YJ (2010) Lymphovascular or perineural invasion may predict lymph node metastasis in patients with T1 and T2 colorectal cancer. J Gastrointest Surg 14:1074–1080

    Article  Google Scholar 

  2. Harris EI, Lewin DN, Wang HL, Lauwers GY, Srivastava A, Shyr Y, Shakhtour B, Revetta F, Washington MK (2008) Lymphovascular invasion in colorectal cancer: an interobserver variability study. Am J Surg Pathol 32:1816–1821

    Article  Google Scholar 

  3. Yuan H, Dong Q, Zheng B, Hu X, Xu JB, Tu S (2017) Lymphovascular invasion is a high risk factor for stage I/II colorectal cancer: a systematic review and meta-analysis. Oncotarget 8:46565–46579

    Article  Google Scholar 

  4. Lim SB, Yu CS, Jang SJ, Kim TW, Kim JH, Kim JC (2010) Prognostic significance of lymphovascular invasion in sporadic colorectal cancer. Dis Colon Rectum 53:377–384

    Article  Google Scholar 

  5. Batsakis JG (1985) Nerves and neurotropic carcinomas. Ann Otol Rhinol Laryngol 94:426–427

    Article  CAS  Google Scholar 

  6. Knijn N, Mogk SC, Teerenstra S, Simmer F, Nagtegaal ID (2016) Perineural invasion is a strong prognostic factor in colorectal cancer: a systematic review. Am J Surg Pathol 40:103–112

    Article  Google Scholar 

  7. Liebig C, Ayala G, Wilks J, Verstovsek G, Liu H, Agarwal N, Berger DH, Albo D (2009) Perineural invasion is an independent predictor of outcome in colorectal cancer. J Clin Oncol 27:5131–5137

    Article  Google Scholar 

  8. Prall F, Nizze H, Barten M (2005) Tumour budding as prognostic factor in stage I/II colorectal carcinoma. Histopathology 47:17–24

    Article  CAS  Google Scholar 

  9. Mitrovic B, Schaeffer DF, Riddell RH, Kirsch R (2012) Tumor budding in colorectal carcinoma: time to take notice. Mod Pathol 25:1315–1325

    Article  CAS  Google Scholar 

  10. Ribeiro MS, Wallace MB (2015) Endoscopic treatment of early cancer of the colon. Gastroenterol Hepatol (N Y) 11:445–452

    Google Scholar 

  11. Koelzer VH, Zlobec I, Lugli A (2016) Tumor budding in colorectal cancer--ready for diagnostic practice? Hum Pathol 47:4–19

    Article  Google Scholar 

  12. Chok KS, Law WL (2007) Prognostic factors affecting survival and recurrence of patients with pT1 and pT2 colorectal cancer. World J Surg 31:1485–1490

    Article  Google Scholar 

  13. Betge J, Langner C (2011) Vascular invasion, perineural invasion, and tumour budding: predictors of outcome in colorectal cancer. Acta Gastroenterol Belg 74:516–529

    PubMed  Google Scholar 

  14. Hase K, Shatney C, Johnson D, Trollope M, Vierra M (1993) Prognostic value of tumor “budding” in patients with colorectal cancer. Dis Colon Rectum 36:627–635

    Article  CAS  Google Scholar 

  15. Sirin AH, Sokmen S, Unlu SM, Ellidokuz H, Sarioglu S (2019) The prognostic value of tumor budding in patients who had surgery for rectal cancer with and without neoadjuvant therapy. Tech Coloproctol 23:333–342

    Article  CAS  Google Scholar 

  16. Graham RP, Vierkant RA, Tillmans LS, Wang AH, Laird PW, Weisenberger DJ, Lynch CF, French AJ, Slager SL, Raissian Y, Garcia JJ, Kerr SE, Lee HE, Thibodeau SN, Cerhan JR, Limburg PJ, Smyrk TC (2015) Tumor budding in colorectal carcinoma: confirmation of prognostic significance and histologic cutoff in a population-based cohort. Am J Surg Pathol 39:1340–1346

    Article  Google Scholar 

  17. Lugli A, Karamitopoulou E, Zlobec I (2012) Tumour budding: a promising parameter in colorectal cancer. Br J Cancer 106:1713–1717

    Article  CAS  Google Scholar 

  18. van Wyk HC, Park J, Roxburgh C, Horgan P, Foulis A, McMillan DC (2015) The role of tumour budding in predicting survival in patients with primary operable colorectal cancer: a systematic review. Cancer Treat Rev 41:151–159

    Article  Google Scholar 

  19. Prall F (2007) Tumour budding in colorectal carcinoma. Histopathology 50:151–162

    Article  CAS  Google Scholar 

  20. Betge J, Kornprat P, Pollheimer MJ, Lindtner RA, Schlemmer A, Rehak P, Vieth M, Langner C (2012) Tumor budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer. Ann Surg Oncol 19:3706–3712

    Article  Google Scholar 

  21. Huh JW, Lee JH, Kim HR, Kim YJ (2013) Prognostic significance of lymphovascular or perineural invasion in patients with locally advanced colorectal cancer. Am J Surg 206:758–763

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Data collection and writing of manuscript are attributed to Seijong Kim. Study proposal, design, analysis, and responsibility to correspondence are attributed to Jung Wook Huh. All authors contributed to the enrollment of patients and approved the final version of the manuscript.

Corresponding author

Correspondence to Jung Wook Huh.

Ethics declarations

The study was approved by the Institutional Review Board of Samsung Medical Center.

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The original version of this article was revised: The name of the author of the original published version of this article was presented incorrectly. The author name “JungWook Huh” should have been presented as “Jung Wook Huh”. This has been correctly presented above.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, S., Huh, J.W., Lee, W.Y. et al. Lymphovascular invasion, perineural invasion, and tumor budding are prognostic factors for stage I colon cancer recurrence. Int J Colorectal Dis 35, 881–885 (2020). https://doi.org/10.1007/s00384-020-03548-4

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-020-03548-4

Keywords

Navigation